Elanco Animal Health (ELAN) Net Income towards Common Stockholders Growth (3y) (2020 - 2026)
Powered by 
Analysis
Elanco Animal Health (ELAN) Net Income towards Common Stockholders Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.46 Bn | 40.26 Bn | 779.09 Mn | 14.70% |
| 2 | Zoetis | 30.65 Bn | 28.98 Bn | 1.05 Bn | -0.23% |
| 3 | Elanco Animal Health | 11.82 Bn | 11.29 Bn | 798.00 Mn | 36.74% |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | 36.15% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 49.33% |
| 6 | Zhengye Biotechnology Holding | 75.29 Mn | 68.19 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -350.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.74% |
| Mar 31, 2026 | -17.90% |
| Dec 31, 2025 | -72.25% |
| Sep 30, 2025 | 19.43% |
| Jun 30, 2025 | 45.81% |
| Mar 31, 2025 | 9.52% |
| Dec 31, 2024 | 57.61% |
| Sep 30, 2024 | 75.12% |
| Jun 30, 2024 | 37.62% |
| Mar 31, 2024 | 35.72% |
| Dec 31, 2023 | 24.13% |
| Sep 30, 2023 | -100.98% |
| Jun 30, 2023 | -22.32% |
| Mar 31, 2023 | 60.08% |
| Dec 31, 2022 | -78.47% |
| Sep 30, 2022 | -104.08% |
| Jun 30, 2022 | -31.59% |
| Mar 31, 2022 | 17.42% |
| Dec 31, 2021 | -103.30% |
| Sep 30, 2021 | -55.97% |